A comprehensive market analysis reveals that the global metabolism assays market, valued at US$ 1.5 billion in 2023, is on a significant growth trajectory. Forecasts estimate the market will expand at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2034, reaching more than US$ 3.1 billion by the end of the forecast period. Prominent players fueling this expansion include Merck KGaA,...